# National HealthCare Corporation (NHC) Stock Analysis: A Healthcare Player with Solid Revenue Growth and Dividend Appeal

- Link: https://www.directorstalkinterviews.com/national-healthcare-corporation-nhc-stock-analysis-a-healthcare-player-with-solid-revenue-growth-and-dividend-appeal/4121211714
- Published: 2025-08-12T10:27:11+01:00
- Author: Madison Wilson

National HealthCare Corporation (NHC) stands as a noteworthy entity within the healthcare
sector, operating a comprehensive range of medical care facilities across the United
States. With a market capitalization of $1.6 billion, NHC’s reach extends into skilled
nursing, assisted and independent living facilities, homecare, and hospice services.
Founded in 1971 and based in Murfreesboro, Tennessee, the company has honed its 
operations to cater to diverse healthcare needs, offering everything from rehabilitative
and memory care services to behavioral health services and managed care insurance
solutions.

Despite the absence of a formal exchange listing in the provided data, NHC’s current
stock price of $103.43 reflects a modest daily change of 0.03%, underscoring its
stability in a volatile market. Over the past 52 weeks, the stock has oscillated
between $89.91 and $137.13, indicating a broad trading range that could appeal to
investors seeking both growth and value opportunities.

However, when it comes to valuation metrics, there is a noticeable lack of available
data, including P/E ratios and PEG ratios, which may pose a challenge for investors
relying on these traditional metrics for their investment decisions. This raises
the importance of examining other performance indicators and financial health metrics.

The company has reported a robust revenue growth of 28.70%, a figure that signifies
strong operational performance and market demand for its services. This growth is
complemented by a return on equity of 10.66%, showcasing effective management in
generating profits from shareholder investments. Furthermore, an earnings per share(
EPS) of 6.70 adds to NHC’s attractiveness, reflecting its capacity to generate earnings.

Investors will be pleased to note NHC’s commitment to shareholder returns through
dividends. With a dividend yield of 2.48% and a payout ratio of 36.87%, the company
strikes a balance between rewarding shareholders and retaining earnings for potential
reinvestment or debt reduction.

On the technical front, NHC’s stock is trading above its 50-day moving average of
$101.92, yet below the 200-day moving average of $104.28. This positioning, coupled
with a Relative Strength Index (RSI) of 73.78, suggests the stock might be overbought,
warranting caution or potential profit-taking for short-term traders. The MACD indicator
at -0.79, along with a signal line of -1.70, further signals potential bearish momentum,
which investors should monitor closely.

Interestingly, the absence of analyst ratings and target prices points to a potential
under-the-radar status for NHC, which can present both risks and opportunities. 
Investors intrigued by the healthcare sector’s potential might find NHC’s operational
strengths and dividend prospects appealing, even though a lack of consensus estimates
necessitates a more hands-on approach to due diligence.

National HealthCare Corporation remains a noteworthy consideration for investors
focused on the healthcare sector. Its solid revenue growth, effective capital management,
and dividend yield offer a compelling case for those looking to balance growth and
income in their portfolios. As always, investors should consider their individual
risk tolerance and investment horizon when evaluating NHC’s potential within their
broader investment strategy.

Share on: